Detailed price information for Biolife Solutions (BLFS-Q) from The Globe and Mail including charting and trades.

Oracle Corporation remains a Buy as surging cloud AI infrastructure demand drives a record $553B backlog and robust revenue ...

Oracle committed to a Capex plan so aggressive that trailing FCF went negative to $24.7B on a TTM basis as of Q3 FY26. See why I rate ORCL stock a Buy.

Debt markets show more concern for Oracle's default risk than Alphabet's. Equity markets are wary of Oracle and Microsoft's exposure to OpenAI. Well-funded leaders like Alphabet may be safer ...

Oracle (NYSE: ORCL | ORCL Price Prediction) has been one of the most volatile mega-caps in the market over the past year, ...

Oracle beat Wall Street's earnings targets but missed the Street's revenue projections. The company is relying on expensive debt to fund its substantial -- and growing -- capital expenditures, making ...

Oracle's backlog grew 325% year over year, reaching $553 billion in the third quarter of fiscal 2026. The company anticipates total revenue reaching $90 billion in 2027. Oracle has a tremendous ...

News that an estimated 30,000 employees are losing their jobs at Oracle comes at a time when the company is claiming to have $533bn in orders to fulfil. As of May 2025, Oracle had a workforce of ...

The East Bank Development Authority is highlighting where the development stands in the first quarter of 2026.

Oracle last 30 days show VA EHR rollout resumption, AI enhancements, and leadership changes advancing healthcare technology and CMS initiatives.

Oracle and BorderPlex Digital Assets will use fuel cells made by Bloom Energy for Oracle's Project Jupiter data-center campus in New Mexico. Bloom will supply the campus with up to 2.45 gigawatts of ...